InSilico Medicine Hong Kong is a technology company that develops AI-based platforms for drug development and discovery. It provides Pharma.AI, a drug discovery engine that utilizes data samples and multiple data types to discover signatures of diseases and identify the targets for molecules; Chemistry42, an automated machine learning platform for drug design capable of finding novel lead-like structures; inClinico, a platform for the data-driven multimodal forecast of a single clinical trial's probability of success (PoS); PandaOmics, an artificial intelligence tool for OMICS data analysis, pathway analysis, and visualization, target, and drug identification.